Skip Navigation
request an appointment my chart notification lp musc-logo-white-01 facebook twitter youtube blog find a provider circle arrow
MUSC mobile menu

Radiation Oncology Blog

A Blog for Radiation Oncology
Date: Jun 2015

June 15 – 21 is honored as Men’s Health Week, a time dedicated to raising awareness for health issues that affect men and encouraging early detection and treatment of disease.

Prostate cancer is one health issue that touches the lives of many men and their families. If you’ve been diagnosed with prostate cancer, consult your physician, speak with your family or others who have been diagnosed with the disease and seek information from organizations that provide support to prostate cancer patients, such as the Prostate Cancer Foundation.

At MUSC Hollings Cancer Center, a comprehensive prostate cancer treatment program offers patients an array of advanced treatment options provided by a multidisciplinary team of physicians with backgrounds in urology, medical oncology, radiation oncology, radiology, interventional radiology and pathology.

Treatments include standard and robotic surgery methods, brachytherapy, cryotherapy and new drug therapies available through MUSC’s clinical trials. MUSC is the only health care institution in South Carolina that offers all four approaches to prostate cancer surgery, also known as prostatectomy.

Learn more about treatment options here. If you or a loved one has been diagnosed with prostate cancer, contact Hollings Cancer Center at 843-792-3271 or submit an inquiry here.

For cancer patients who smoke, Hollings Cancer Center at the Medical University of South Carolina offers a dedicated smoking cessation program. smoking cessation

Clinicians and researchers at Hollings developed the program, which includes an automated referral process for patients. Using a tobacco assessment, patients are screened for tobacco use and those who are shown to have used tobacco within 30 days of the assessment are referred to the smoking cessation program.

Patients can opt out of the program, but it is a standard of care offered to all patients at Hollings. The service includes the development of an individualized cessation treatment plan.

The new service for patients was featured in a recent article authored by MUSC associate professor and vice chairman of research Graham W. Warren, MD, Ph.D. and MUSC professor K. Michael Cummings, Ph.D., MPH. The article appeared in Oncology Live. Read more here.

June is Men’s Health Month, a period focused on increasing awareness and promoting education around prevention anMen's Health Monthd early detection of health issues affecting men.

One of the most commonly diagnosed diseases in men, prostate cancer is expected to be diagnosed in more than 220,000 men in the U.S in 2015, according to the American Cancer Society.

A team of researchers with the Medical University of South Carolina recently completed a study that shows vitamin D supplements could keep low-grade prostate cancer from progressing and becoming more aggressive.

Led by MUSC scientist Bruce Hollis, Ph.D., the research team conducted a randomized, controlled clinical trial in which 37 men undergoing elective prostatectomies were assigned either to a group that received vitamin D supplements daily, or to a placebo group that did not receive vitamin D.

Preliminary results indicate that many of the men who received vitamin D showed improvements in their prostate tumors, whereas the tumors in the placebo group either stayed the same or worsened. The findings suggest that vitamin D supplements may improve low-grade prostate cancers by reducing inflammation.

"We don't know yet whether vitamin D treats or prevents prostate cancer," says Hollis. "At the minimum, what it may do is keep lower-grade prostate cancers from going ballistic."

Learn more about research programs at MUSC here or search active clinical trials available at Hollings Cancer Center here.